In December of 2020, IPWatchdog hosted a webinar discussing the use of and interest in solid-form patents in the pharmaceutical industry. There were many questions during the webinar, and many follow-up inquiries on the “nuts and bolts” of these patents. Issues including prosecution, claim drafting, novelty, obviousness, enablement, non-species claims in a crystalline-form context, claim interpretation and proving infringement.
Join us on for this follow-on webinar that will dive deeper into these questions from a US-based perspective, and which will also compare and contrast these issues with elements of EU law. Panelists will discuss both court decisions as well as opinions from the USPTO (PTAB) and the EPO.
Moderated by Gene Quinn, patent attorney and founder of IPWatchdog.com, with expert commentary and analysis from Eyal Barash, IP Counsel and founder of Barash Law, LLC.